11/22
04:18 pm
anik
Anika To Participate in December 2024 Investor Conferences [Yahoo! Finance]
Neutral
Report
Anika To Participate in December 2024 Investor Conferences [Yahoo! Finance]
11/22
04:16 pm
anik
Anika To Participate in December 2024 Investor Conferences
Neutral
Report
Anika To Participate in December 2024 Investor Conferences
11/11
03:37 am
anik
New Strong Sell Stocks for November 11th [Yahoo! Finance]
Low
Report
New Strong Sell Stocks for November 11th [Yahoo! Finance]
11/4
11:12 pm
anik
Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
11/1
10:34 am
anik
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.
Low
Report
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.
11/1
07:29 am
anik
Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Medium
Report
Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
10/31
11:00 am
anik
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
Medium
Report
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
10/31
07:11 am
anik
Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
10/31
07:05 am
anik
Anika Reports Third Quarter 2024 Financial Results
High
Report
Anika Reports Third Quarter 2024 Financial Results
10/31
07:00 am
anik
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
High
Report
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
10/22
10:46 am
anik
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Low
Report
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
10/17
04:01 pm
anik
Anika Announces Third Quarter 2024 Results Conference Call Date
Low
Report
Anika Announces Third Quarter 2024 Results Conference Call Date
10/4
04:01 pm
anik
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/17
07:43 am
anik
Adhesion Barrier Market to Reach $1.5 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research [Yahoo! Finance]
Low
Report
Adhesion Barrier Market to Reach $1.5 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research [Yahoo! Finance]
9/9
04:45 pm
anik
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)